Gomez-Escobar, Elsa
Burlaud-Gaillard, Julien
Visdeloup, Clara
Ribeiro E Silva, Adeline
Coutant, Pauline
Roingeard, Philippe
Beaumont, Elodie
Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales
Conseil Régional du Centre-Val de Loire
Ligue Contre le Cancer
Article History
Received: 15 February 2021
Accepted: 27 October 2021
First Online: 8 November 2021
Change Date: 18 September 2022
Change Type: Update
Change Details: The original online version of this Article was revised: In the original version of this Article, the author name Adeline Ribeiro E Silva was incorrectly indexed. The original Article has been corrected.
Competing interests
: PR is co-inventor of the patent “Novel fusion proteins and use thereof for preparing hepatitis C vaccines”; EGE, PR and EB are co-inventors of the patent “New immunogenic compositions and their use in the preparation of vaccines against hepatitis C and hepatitis B”. The remaining authors declare no competing interests.